Matt Reeser

Matt Reeser is an experienced professional in program management and project oversight, currently serving as Director of Program Management at Checkpoint Therapeutics Inc since January 2022. Prior to this role, Matt held various positions at Eisai US from May 2008 to January 2022, including Associate Director and Senior Program Manager. Matt's career began at Charles River Laboratories, Biopharmaceutical Services, where responsibilities included Senior Supervisor of Mammalian Cell Banking and Cell Culture Technician from July 2003 to May 2008. Additional experience includes serving as Project Manager in R&D at Morphotek, Inc. from June 2008 to May 2012 and working as a lab technician at Penn State University from 2000 to 2001. Matt Reeser earned a Bachelor of Science degree in Microbiology from Penn State University between 1996 and 2000.